Literature DB >> 11352839

Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function.

S Xiao1, A Erdely, L Wagner, C Baylis.   

Abstract

In vitro, 7 days of high blood urea nitrogen (BUN) inhibits endothelial L-arginine transport and nitric oxide synthase (NOS) activity. The present study investigates whether 7 days of high BUN in vivo influences renal hemodynamics, blood pressure (BP), and/or the nitric oxide (NO) system. Normal rats were fed low-nitrate food containing 30% urea for 7 days, which increased BUN (15 +/- 1 to 69 +/- 4 mg/100 ml, P < 0.001). High BUN did not reduce 24-hour urinary nitrite/nitrate excretion (a measure of total NO production). Baseline BP and renal hemodynamics were unaffected by high BUN as were the pressor and renal vasoconstrictor responses to acute NOS inhibition with N(G)-nitro-L-arginine-methyl ester. In addition, high BUN had no impact on renal cortical L-arginine concentration, density of either endothelial NOS or neuronal NOS protein, or renal cortical NOS activity. NOS activity in the brain cerebellum was also unaffected. In conclusion, high BUN did not lead to vasoconstriction or NO deficiency in rats with normal renal function. Further studies are needed to evaluate the effect of high BUN on the NO system in rats with progressive renal functional insufficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352839     DOI: 10.1152/ajprenal.2001.280.6.F996

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  17 in total

1.  Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells.

Authors:  S Xiao; L Wagner; J Mahaney; C Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2001-06

2.  Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat.

Authors:  Aaron Erdely; Gary Freshour; Cheryl Smith; Kevin Engels; Jean L Olson; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2004-03-23

3.  Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade.

Authors:  Jennifer M Sasser; Natasha C Moningka; Tatsiana Tsarova; Chris Baylis
Journal:  Life Sci       Date:  2012-06-19       Impact factor: 5.037

4.  Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(ω)-nitro-L-arginine methyl ester hypertensive rats.

Authors:  Jennifer M Sasser; Miklos Molnar; Chris Baylis
Journal:  Hypertension       Date:  2011-06-13       Impact factor: 10.190

5.  Angiotensin II regulates NOS expression in afferent arterioles of the developing porcine kidney.

Authors:  Brian B Ratliff; Miroslav Sekulic; Justin Rodebaugh; Michael J Solhaug
Journal:  Pediatr Res       Date:  2010-07       Impact factor: 3.756

6.  Impact of the estrus cycle and reduction in estrogen levels with aromatase inhibition, on renal function and nitric oxide activity in female rats.

Authors:  Beth R Santmyire; Vasuki Venkat; Ernst Beinder; Chris Baylis
Journal:  Steroids       Date:  2010-07-07       Impact factor: 2.668

7.  Urea transporters are distributed in endothelial cells and mediate inhibition of L-arginine transport.

Authors:  Laszlo Wagner; Janet D Klein; Jeff M Sands; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2002-09

8.  Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase.

Authors:  Aaron Erdely; Laszlo Wagner; Veronica Muller; Attila Szabo; Chris Baylis
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

9.  Asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Natasha C Moningka; Mark W Cunningham; Byron Croker; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-16       Impact factor: 3.619

10.  Renal redox response to normal pregnancy in the rat.

Authors:  Mark W Cunningham; Jennifer M Sasser; Crystal A West; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-01-02       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.